Invivyd Reports Q1 Net Loss of $41.4M, EPS of -$0.13
IVVD has more than doubled off its 52-week low of $0.483.
Summary
Invivyd reported a Q1 net loss of $41.4 million, translating to an EPS of -$0.13, on revenue of $13.744 million. This financial update follows the company's 2025 annual report, which included a 'going concern' warning, indicating persistent financial challenges. The continued net loss reinforces the financial pressures previously disclosed and will be a key focus for investors. Traders will be monitoring future financial reports for any signs of improved profitability or further strategic actions to address the company's ongoing financial health.
At the time of this announcement, IVVD was trading at $1.40 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $415.7M. The 52-week trading range was $0.48 to $3.07. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.